SoundCure Serenade for tinnitus
SoundCure Inc announced the receipt of a medical device license from Health Canada, a department of the Canadian government, for the SoundCure Serenade Tinnitus Treatment System. The medical license enables the SoundCure Serenade to be available in Canada.
Levo tinnitus system
Otoharmonics Corporation announced the US patent approval for certain elements of its Levo tinnitus system. Utilizing an FDA-cleared neuroscience-based approach, the Levo system offers a method for providing personalized sound therapy while sleeping.
Otoharmonics Levo System
Otoharmonics Corporation, Portland, Ore, has announced that a new peer-reviewed study using its Levo System for tinnitus showed a reduction in tinnitus symptoms and improvement in daily outlook for many study participants.
Figure 4
Previous tinnitus studies have demonstrated the benefits of fractal tones and Widex Zen Therapy (WZT) when used in conjunction with amplification, but there have been no studies on the use of fractal tones alone for tinnitus sufferers who do not require or wish to consider amplification. Until now...
More than half the participants who completed TMS sessions on 10 consecutive workdays found their tinnitus symptoms were alleviated for at least six months.
Researchers at Yale University School of Medicine conducted a retrospective analysis and found that workers with a history of tinnitus in conjunction with high-frequency hearing loss are more likely to be injured.
Tinnitus Treatment Solutions, which uses telemedicine to provide comprehensive nationwide tinnitus care and counseling, has announced an expanded range of products and accessories for relief of ringing ears.
Relax tinnitus app
Starkey Hearing Technologies has introduced Relax, a mobile app designed to help provide personalized tinnitus relief and comprehensive tinnitus education. Relax has 12 relief sounds, and is the company's next step in providing tinnitus management strategies that are unique to each user’s tinnitus symptoms.
Figure 1
Choosing the correct sound to use in sound therapy can often have a significant impact on treatment outcomes. Flexibility in today’s technology presents an array of sounds and tinnitus solutions for patients to choose from, allowing for true personalization.
Figure 2
This article provides a primer on sound therapy for tinnitus, including approaches to setting the sound therapy signal for patients with and without hearing loss. It also looks at therapy signal alternatives, including the new Ocean Waves Therapy Signals in the Sivantos binax devices.
Dr Maurice Miller reminds us that tinnitus can be a sign of an "ear in distress" and that hearing care professionals have an obligation to keep this in mind, while offering a continuum of tinnitus solutions—not just hearing aids.
Tinnitus Treatment Solutions (TTS), a provider of care and services for people suffering from tinnitus, has announced that it is now offering top-brand tinnitus hearing aids, and will soon be offering tinnitus accessories nationwide.
Tinnitus Mapping on Brain
Researchers have taken advantage of a rare opportunity to record and map tinnitus in the brain of a patient undergoing surgery, with the goal of finding the brain networks responsible for this condition characterized by "phantom noise."
misophonia or sound rage
A UCSF pilot study shows that mindfulness is a treatment approach for tinnitus that may help the roughly 50 million Americans who suffer from the condition, providing longterm relief.
Mazevski Figure 1
Tinnitus SoundSupport (TSS) encompasses ease of use along with flexibility and variety to promote an uncomplicated fitting process for the audiologist and significant relief for the tinnitus patient.

Data Watch

Powered By:
Oticon Performance Line Alta2 hearing instruments
Oticon introduced its new Inium Sense, a sound processing platform that powers the company's new Alta2, Nera2, and Ria2 hearing aids in its Performance Line of hearing instruments.
Fig 5
A look at the long-term effectiveness of an integrated tinnitus management approach (WZT) and the pattern of therapy use among primary tinnitus patients once successful remediation of symptoms is achieved.
The UK-based charity, Action on Hearing Loss, announced that it is funding a tinnitus study at Newcastle University to help accelerate the development of future tinnitus treatments.
Sanuthera announced that it has submitted its Serenity tinnitus device to the FDA for 510(k) clearance.
Quell device
Amplisound has announced the release of a new tinnitus device called Quell, which is designed to be used effectively with any tinnitus therapy. While there are many devices available for tinnitus relief, including hearing aids, Quell is particularly suitable for patients who respond specifically to sound therapy and do not want a hearing aid or need amplification.